ORAL MINOCYCLINE MAY BE USED TO TREAT DIABETIC MACULAR EDEMA

http://www.iovs.org/content/early/2012/05/11/iovs.11-9413.abstract

Conclusions: In this pilot proof-of-concept study of DME, minocycline as primarytreatment was associated with improved visual function, central macular edema and vascular leakage, comparing favorably with historical controls from previous studies. Microglial inhibition with oral minocycline may be a promising therapeutic strategy targeting the inflammatory etiology of DME.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH